Biogennix
-
Biologics
Comparing the Cellular Effects of Bone Graft Materials: Nanosurfaces vs. Bioglass
Biogennix, February 22, 2023 – OrthoSpineNews – Featured Article One of the critical functions of a bone graft material is to…
Read More » -
Top Stories
Biogennix’s DirectCell Advanced Bone Grafting System Used in 1000th Case
IRVINE, Calif. – November 29, 2022 /OrthoSpineNews/ – Irvine-based Biogennix, a market leader in advanced bone regeneration technology, announced today…
Read More » -
Biologics
Mechanisms of Action for Biologically Active Bone Graft Materials
Biogennix, November 8, 2022 – OrthoSpineNews – Featured Article Biologically active bone grafts are being increasingly favored by surgeons due to…
Read More » -
Biologics
Types of Synthetic Bone Graft Products: Active vs. Passive Materials
Advanced bone graft materials play an active role in the bone healing process by positively influencing cellular healing. Biogennix, October…
Read More » -
Top Stories
Biogennix Reports Record Quarter and Half-Year Sales
Bone Regeneration Company Sets Multiple Sales Record Marks Despite Challenging Market Conditions IRVINE, Calif. — August 10, 2022 /OrthoSpineNews/ —…
Read More » -
Biologics
Biogennix’s DirectCell Advanced Bone Grafting System Used in 500th Case
IRVINE, Calif. – May 17, 2022 / OrthoSpineNews / – Irvine-based Biogennix, a market leader in advanced bone regeneration technology,…
Read More » -
Biologics
Biogennix Reports Record Year for Sales in 2021
IRVINE, Calif., January 25, 2022 / OrthoSpineNews / – Irvine-based Biogennix, an advanced osteobiologics company that develops, manufactures, and distributes…
Read More » -
Biologics
Biogennix Celebrates a Decade of Innovation and Clinical Success
IRVINE, Calif. — June 29, 2021 — Irvine-based Biogennix, an advanced osteobiologics company that develops, manufactures, and distributes proprietary bone…
Read More » -
Biologics
Biogennix’s Agilon Moldable Bone Graft Solution Achieves Sales Surge Amid Adoption by Foot and Ankle Surgeons
IRVINE, Calif. — May 19, 2021 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Biogennix Launches Agilon Strip Advanced Bone Grafting Solution
IRVINE, Calif. — April 14, 2021 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Biogennix Remains Operational as it Prepares for Post-Coronavirus Surgical Demand
IRVINE, Calif. — April 14, 2020 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures
March 04, 2020 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Biologics
Biogennix Reports Record Year for Sales
IRVINE, Calif. — December 18, 2019 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone grafting…
Read More » -
Biologics
Biogennix Launches Agilon Bone Grafting Solution
September 04, 2019 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Biologics
Biogennix Names Robert Baizer CFO
February 05, 2019 IRVINE, Calif.–(BUSINESS WIRE)–Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft substitutes used for…
Read More »